Patents Assigned to Lipopharma Therapeutics, S.L.
-
Patent number: 11253497Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: April 22, 2020Date of Patent: February 22, 2022Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Publication number: 20200352891Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: April 22, 2020Publication date: November 12, 2020Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Publication number: 20190365690Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: ApplicationFiled: December 18, 2018Publication date: December 5, 2019Applicant: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente ESCRIBA RUIZ, Xavier BUSQUETS XAUBET, Maria Laura MARTIN, Rafael ALVAREZ MARTINEZ, Victoria LLADO CANELLAS
-
Patent number: 10201515Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: August 22, 2017Date of Patent: February 12, 2019Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9907772Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: July 13, 2016Date of Patent: March 6, 2018Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9763906Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9763907Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: September 29, 2015Date of Patent: September 19, 2017Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Maria Laura Martin, Rafael Alvarez Martinez, Victoria Llado Canellas
-
Patent number: 9161928Abstract: Use of polyunsaturated fatty acid derivatives as medicaments or functional foods. The present invention relates to the use of 1,2-fatty acid derivatives in the treatment or prevention of common diseases whose etiology is based on alterations (of any type) of the cell membrane lipids, for example, changes in levels, in the composition or in the structure of these lipids. In addition, for diseases in which the regulation of lipid composition and of the structure of the membranes (or proteins that interact with membranes) causes the reversion of pathological state.Type: GrantFiled: March 15, 2010Date of Patent: October 20, 2015Assignee: Lipopharma Therapeutics, S.L.Inventors: Pablo Vicente Escriba Ruiz, Xavier Busquets Xaubet, Silvia Teres Jimenez, Gwendolyn Barcelo Coblijn, Victoria Llado Canellas, Amaia Marcilla Etxenike, Maria Laura Martin, Monica Higuera Urbano, Rafael Alvarez Martinez, Daniel Horacio Lopez